Table 1 Clinical and pathological features of EOC patients
Characteristics | Age (years) | Pathological type | FIGO stage | Grade | progression-free survival (months) |
|---|---|---|---|---|---|
EOC1 | 66 | serous mucinous carcinoma | IIIA1(i) | Low |  > 6 |
EOC2 | 62 | serous carcinoma | IIIA2 | Moderate |  > 6 |
EOC3 | 70 | mucinous carcinoma | IVA | High |  > 6 |
EOC4 | 65 | serous carcinoma | IIIC | High |  > 6 |
EOC5 | 63 | serous mucinous carcinoma | IIIC | Moderate |  > 6 |
EOC6 | 64 | serous carcinoma | IVA | Moderate |  > 6 |
EOC7 | 68 | serous carcinoma | IIIC | High |  > 6 |
EOC8 | 67 | clear cell carcinoma | IVA | High |  > 6 |
EOC9 | 69 | endometrioid carcinoma | IIIA1(ii) | Low |  > 6 |
EOC10 | 71 | mucinous carcinoma | IIIC | Moderate |  > 6 |
EOC11 | 65 | serous carcinoma | IVA | Low |  > 6 |
EOC12 | 59 | serous carcinoma | IVA | High |  > 6 |
EOC13 | 60 | serous carcinoma | IIIC | High |  < 6 |
EOC14 | 68 | serous mucinous carcinoma | IIIC | Low |  < 6 |
EOC15 | 68 | mucinous carcinoma | IVA | High |  < 6 |
EOC16 | 65 | clear cell carcinoma | IIIC | High |  < 6 |
EOC17 | 66 | serous carcinoma | IIIB | Moderate |  < 6 |
EOC18 | 69 | serous carcinoma | IIIA2 | Moderate |  < 6 |
EOC19 | 72 | serous carcinoma | IIIC | High |  < 6 |
EOC20 | 66 | serous carcinoma | IIIB | High |  < 6 |
EOC21 | 70 | serous carcinoma | IVB | High |  < 6 |
EOC22 | 65 | serous carcinoma | IIIC | Moderate |  < 6 |
EOC23 | 76 | serous carcinoma | IIIC | High |  < 6 |
EOC24 | 60 | serous carcinoma | IVA | High |  < 6 |